Miguel Martin

Editor’s note: This article has been updated to reflect the accurate percentage of the German population participating in the medical cannabis market. Shares of Aurora Cannabis Inc (NASDAQ:ACB) fell roughly 20% on Wednesday following the company's fiscal Q4 and full-year 2025 earnings report...

Canadian medical marijuana giant Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) reported its financial results Wednesday for the second quarter of fiscal 2025, showing revenue of CA$81.1 million ($58.3 million), up from CA$63.1 million in the same period last year. The company attributed the 29%...

Canadian medical cannabis giant Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) announced on Friday the appointments of CEO Miguel Martin to the additional role of executive chairman and outgoing chairman Ron Funk as lead independent director. Both are backed by unanimous votes by the company's board...

Canadian medical cannabis company Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) and Vectura Fertin Pharma, Inc., an innovator in wellness and healthcare, announced on Monday the launch of the newly developed Luo CBD lozenge. What Happened The product was developed by Vectura Fertin Pharma, and...

Aurora Cannabis Inc. (NASDAQ:ACB) has partnered with Vectura Fertin Pharma, Inc. to launch a CBD lozenge in the form of a dissolvable tablet that delivers the precise dose of cannabidiol (CBD). The new product is expected to enhance patient care by providing an alternative consumption method...

Canadian medical marijuana giant Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) reported its financial and operational results Wednesday for the first quarter of fiscal 2025, revealing revenue of CA$83.44 million ($60.72 million) compared to CA$74.73 million in the same period of fiscal 2024. Aurora...

Canadian medical marijuana giant Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) partnered with Cogent International Manufacturing Ltd., a subsidiary of wellness innovator Vectura Fertin Pharma Inc. Under this commercial collaboration, Cogent will initially launch its newly developed CBD lozenge on...

Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) announced its financial and operational results Thursday for the fourth quarter and fiscal year 2024. The Alberta-based cannabis giant noted the year-over-year comparison quarter for the fourth quarter of 2024 ending March 31, 2024, is the third quarter...

Adults over 18 in Germany can legally possess up to 25 grams of dried cannabis and cultivate up to three marijuana plants at home. And no, this is not an April Fools' Day prank. Beginning July 1, adults can also join not-for-profit social clubs where they can buy up to 25 grams of cannabis, with a...

In a recent analysis by Canaccord Genuity, the Canadian cannabis giant Aurora Cannabis Inc (NASDAQ:ACB) has seen its investment recommendation upgraded from “hold” to “buy,” reflecting the company’s strategic strides and financial health. This decision reflects a...

In a revealing interview on Benzinga's Cannabis Insider podcast, Miguel Martin, CEO of Aurora Cannabis Inc (NASDAQ:ACB), offered an in-depth look into the company’s remarkable journey and strategic milestones, particularly highlighting their significant achievements in the global medical...

Canadian medical cannabis giant Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) reported its financial and operational results on Thursday for the third quarter of fiscal year 2024. CEO Miguel Martin said that medical cannabis net revenue has increased significantly year-over-year, adding the third...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), a major cannabis company, is sticking to its previous financial predictions. Management believes the company will make more money than it spends over the year, achieving positive annual adjusted EBITDA, and also expects to have more cash coming in than...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced its financial and operational results for the second quarter of fiscal year 2024, ending September 30, 2023, revealing a record positive adjusted EBITDA of CAD $3.4 million. Miguel Martin, CEO of Aurora, stated: "This is our strongest...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced Tuesday that it had successfully completed a confidential settlement ‎resolving an ongoing patent litigation with Willow Biosciences Inc. (OTCQB: CANSF) (TSX: WLLW).  Aurora undertook the patent infringement action in July...